speb/financial-data huggingface dataset:
BABY.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 4393000.00
BABY.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -1370000.00
BABY.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 924000.00
BABY.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -1370000.00
BABY.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 2241000.00
BABY.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 5763000.00
BABY.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 426000.00
BABY.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
BABY.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -221000.00
BABY.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -221000.00
BABY.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: -1796000.00
BABY.TO income_statement (annual, 2025-12-31) — +Operating Expense: 6658000.00
BABY.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 1975000.00
BABY.TO income_statement (annual, 2025-12-31) — +Total Revenue: 6025000.00
BABY.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 776000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 1966000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1966000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 609000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 609000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -454000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -454000.00
BABY.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 34248799.00
BABY.TO income_statement (annual, 2025-12-31) — Basic EPS: -0.26
BABY.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 47000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 72000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 0.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 0.00
BABY.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 76517000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 76517000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 152000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 152000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 152000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 152000.00
BABY.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2890000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1267000.00
BABY.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 327000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -23000.00
BABY.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -3184000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -924000.00
BABY.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: -789000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 485000.00
BABY.TO cash_flow (annual, 2025-12-31) — Change In Inventory: 3026000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: 821000.00
BABY.TO cash_flow (annual, 2025-12-31) — Change In Payable: -393000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: 905000.00
BABY.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -393000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 905000.00
BABY.TO cash_flow (annual, 2025-12-31) — Change In Receivables: 660000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 427000.00
BABY.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: 3293000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 2153000.00
BABY.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 220000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 213000.00
BABY.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 33000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 320000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Common Stock: 76517000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 76517000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: -4076000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -4076000.00
BABY.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 503000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
BABY.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 5705000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1481000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 2301000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 2301000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Current Assets: 2770000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 2770000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 0.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 0.00
BABY.TO balance_sheet (annual, 2025-12-31) — Current Debt: 1858000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 1858000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1858000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1858000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 7198000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 7198000.00
BABY.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 284000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 67000.00
BABY.TO income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 284000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 67000.00
BABY.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 284000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 67000.00
BABY.TO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 284000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 67000.00
BABY.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 34248799.00
BABY.TO income_statement (annual, 2025-12-31) — Diluted EPS: -0.26
BABY.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -8880000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -3238000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 79000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 79000.00
BABY.TO income_statement (annual, 2025-12-31) — EBIT: -7564000.00
BABY.TO income_statement (quarterly, 2025-12-31) — EBIT: -2136000.00
BABY.TO income_statement (annual, 2025-12-31) — EBITDA: -7280000.00
BABY.TO income_statement (quarterly, 2025-12-31) — EBITDA: -2069000.00
BABY.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 72000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -240000.00
BABY.TO cash_flow (annual, 2025-12-31) — End Cash Position: 152000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 152000.00
BABY.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 2890000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 1267000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Finished Goods: 791000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 791000.00
BABY.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: -3184000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -924000.00
BABY.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -692000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -1858000.00
BABY.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: -55000.00
BABY.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 500000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 1599000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2000.00
BABY.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 3608000.00
BABY.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1244000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Goodwill: 54000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 54000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 143000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 143000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 663000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 663000.00
BABY.TO income_statement (annual, 2025-12-31) — Gross Profit: 320000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Gross Profit: -705000.00
BABY.TO income_statement (annual, 2025-12-31) — Interest Expense: 1316000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 1102000.00
BABY.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1316000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1102000.00
BABY.TO income_statement (annual, 2025-12-31) — Interest Income: 4000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Interest Income: 0.00
BABY.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 4000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 0.00
BABY.TO cash_flow (annual, 2025-12-31) — Interest Paid Cfo: -219000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Inventory: 1941000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 1941000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Invested Capital: -2218000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: -2218000.00
BABY.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: 327000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -23000.00
BABY.TO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 503000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
BABY.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 3140000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 1872000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Leases: 79000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Leases: 79000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Line Of Credit: 0.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 0.00
BABY.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 2040000.00
BABY.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -140000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -37000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 277000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 277000.00
BABY.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 503000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
BABY.TO balance_sheet (annual, 2025-12-31) — Net Debt: 1706000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 1706000.00
BABY.TO income_statement (annual, 2025-12-31) — Net Income: -8880000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Net Income: -3238000.00
BABY.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -8880000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -3238000.00
BABY.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -8880000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -3238000.00
BABY.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -8880000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -3238000.00
BABY.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -8880000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -3238000.00
BABY.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -8880000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -3238000.00
BABY.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -8880000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -3238000.00
BABY.TO income_statement (annual, 2025-12-31) — Net Interest Income: -1312000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -1102000.00
BABY.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
BABY.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 2387000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 1267000.00
BABY.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 1900000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 2003000.00
BABY.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1312000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1102000.00
BABY.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 285000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 8000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Net PPE: 209000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 209000.00
BABY.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 42000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -31000.00
BABY.TO cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 487000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -736000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -4219000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -4219000.00
BABY.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: -7725000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -3613000.00
BABY.TO income_statement (annual, 2025-12-31) — Normalized Income: -9325000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Normalized Income: -4782000.00
BABY.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -3184000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -924000.00
BABY.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -692000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -1858000.00
BABY.TO income_statement (annual, 2025-12-31) — Operating Income: -6338000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Operating Income: -2680000.00
BABY.TO income_statement (annual, 2025-12-31) — Operating Revenue: 6025000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 776000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 39926177.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 39926177.00
BABY.TO balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 1858000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 1858000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 836000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 836000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -2000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -2000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Other Equity Interest: 7948000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 7948000.00
BABY.TO income_statement (annual, 2025-12-31) — Other Gand A: 962000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 607000.00
BABY.TO income_statement (annual, 2025-12-31) — Other Income Expense: -1230000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 544000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 89000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 89000.00
BABY.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 3016000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 2359000.00
BABY.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -1675000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -1000000.00
BABY.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 977000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 252000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Other Payable: 158000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 158000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Other Properties: 307000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 307000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 38000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 38000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Payables: 2203000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Payables: 2203000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 4504000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 4504000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 11000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 11000.00
BABY.TO income_statement (annual, 2025-12-31) — Pretax Income: -8880000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Pretax Income: -3238000.00
BABY.TO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
BABY.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
BABY.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: 0.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 0.00
BABY.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 1063000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 1063000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Receivables: 647000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 647000.00
BABY.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 5705000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1481000.00
BABY.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 284000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 67000.00
BABY.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -753000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -605000.00
BABY.TO income_statement (annual, 2025-12-31) — Research And Development: 21000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Research And Development: 20000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Restricted Cash: 19000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 19000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: -88539000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -88539000.00
BABY.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 2646000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 637000.00
BABY.TO cash_flow (annual, 2025-12-31) — Sale Of PPE: 42000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Sale Of PPE: -31000.00
BABY.TO income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 1768000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 392000.00
BABY.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 5376000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1636000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Share Issued: 39926177.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 39926177.00
BABY.TO cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 1100000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: -168000.00
BABY.TO cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -613000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: -568000.00
BABY.TO income_statement (annual, 2025-12-31) — Special Income Charges: -55000.00
BABY.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 14000.00
BABY.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: -9000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: -4076000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -4076000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: -4219000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -4219000.00
BABY.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BABY.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BABY.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
BABY.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
BABY.TO balance_sheet (annual, 2025-12-31) — Total Assets: 3122000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 3122000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: -4076000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -4076000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Total Debt: 1858000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 1858000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -4076000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -4076000.00
BABY.TO income_statement (annual, 2025-12-31) — Total Expenses: 12363000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 3456000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 7198000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 7198000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 352000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 352000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
BABY.TO income_statement (annual, 2025-12-31) — Total Unusual Items: 445000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 1544000.00
BABY.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 445000.00
BABY.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 1544000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Work In Process: 87000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Work In Process: 87000.00
BABY.TO balance_sheet (annual, 2025-12-31) — Working Capital: -4428000.00
BABY.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: -4428000.00
BABY.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 1203000.00
BABY.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 1472000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2634000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1020000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 44382976.00
BABY.TO income_statement (quarterly, 2026-03-31) — Basic EPS: -0.01
BABY.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 152000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 77122000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 225000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 225000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 565000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -484000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 634000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: 516000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Change In Payable: -109000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -109000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: -509000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -102000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -424000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 80000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 77122000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -4088000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 605000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 887000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 2881000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Current Debt: 2010000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2010000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 7308000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 7000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 20000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 7000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 20000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 44382976.00
BABY.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.01
BABY.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -558000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 39000.00
BABY.TO income_statement (quarterly, 2026-03-31) — EBIT: -460000.00
BABY.TO income_statement (quarterly, 2026-03-31) — EBITDA: -440000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -7000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 225000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 565000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -484000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 22000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 239000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -62000.00
BABY.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 665000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 139000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 200000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 585000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 98000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 98000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Interest Income: 0.00
BABY.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 0.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Interest Received Cfo: 65000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 1482000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: -2078000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -1000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 605000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 0.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 605000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 1785000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Net Income: -558000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -558000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -558000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -558000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -558000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -558000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -558000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -98000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -40000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
BABY.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -98000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -1000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 200000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 0.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -40000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -4227000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -679000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Normalized Income: -797000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -484000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 22000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Operating Income: -618000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 1472000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 47941112.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 2010000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 858000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -62000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 7949000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 80000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 158000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 81000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -81000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 231000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Other Payable: 1767000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 200000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 134000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Payables: 4440000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 4440000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Pretax Income: -558000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 0.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 1154000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 900000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 7000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -40000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Research And Development: 17000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 20000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -89097000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 585000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
BABY.TO income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 270000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 935000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 47941112.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 0.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -40000.00
BABY.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -4088000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -4227000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BABY.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 3220000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -4088000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 2010000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -4088000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 2090000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 7308000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 339000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
BABY.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: 239000.00
BABY.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 239000.00
BABY.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: -4427000.00
BAC cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
BAC balance_sheet (annual, 2021-12-31) — Current Accrued Expenses: 198963000000.00
BAC income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 1421000000.00
BAC balance_sheet (annual, 2021-12-31) — Payables And Accrued Expenses: 198963000000.00
BAC income_statement (annual, 2022-12-31) — +Total Revenue: 94950000000.00
BAC balance_sheet (annual, 2022-12-31) — Accounts Receivable: 67543000000.00
BAC balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 9206000000.00
BAC income_statement (annual, 2022-12-31) — Basic Average Shares: 8113700000.00
BAC income_statement (annual, 2022-12-31) — Basic EPS: 3.21
BAC cash_flow (annual, 2022-12-31) — Beginning Cash Position: 348221000000.00
BAC balance_sheet (annual, 2022-12-31) — Capital Stock: 87350000000.00
BAC balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 237462000000.00
BAC balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 505036000000.00
BAC cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -8576000000.00
BAC balance_sheet (annual, 2022-12-31) — Cash Financial: 30334000000.00
BAC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -106039000000.00
BAC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -2529000000.00
BAC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -6327000000.00
BAC cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 23029000000.00
BAC cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 20799000000.00
BAC cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -95772000000.00
BAC cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 23029000000.00
BAC cash_flow (annual, 2022-12-31) — Change In Working Capital: -51944000000.00
BAC cash_flow (annual, 2022-12-31) — Changes In Cash: -114895000000.00
BAC balance_sheet (annual, 2022-12-31) — Common Stock: 58953000000.00
BAC balance_sheet (annual, 2022-12-31) — Common Stock Equity: 244800000000.00
BAC cash_flow (annual, 2022-12-31) — Common Stock Payments: -5073000000.00
BAC balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 222533000000.00
BAC balance_sheet (annual, 2022-12-31) — Current Debt: 26932000000.00
BAC balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 26932000000.00
BAC cash_flow (annual, 2022-12-31) — Deferred Income Tax: 739000000.00
BAC cash_flow (annual, 2022-12-31) — Deferred Tax: 739000000.00
BAC cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1978000000.00
BAC cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1978000000.00
BAC balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 44816000000.00
BAC income_statement (annual, 2022-12-31) — Diluted Average Shares: 8167500000.00
BAC income_statement (annual, 2022-12-31) — Diluted EPS: 3.19
BAC income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 26015000000.00
BAC cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -3123000000.00
BAC cash_flow (annual, 2022-12-31) — End Cash Position: 230203000000.00
BAC cash_flow (annual, 2022-12-31) — Financing Cash Flow: -106039000000.00
BAC cash_flow (annual, 2022-12-31) — Free Cash Flow: -6327000000.00
BAC cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -32000000.00
BAC income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 0.00
BAC balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -21156000000.00
BAC income_statement (annual, 2022-12-31) — General And Administrative Expense: 40468000000.00
BAC balance_sheet (annual, 2022-12-31) — Goodwill: 69022000000.00
BAC balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 69022000000.00
BAC balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 632825000000.00
BAC cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 2288000000.00
BAC income_statement (annual, 2022-12-31) — Interest Expense: 20103000000.00
BAC income_statement (annual, 2022-12-31) — Interest Income: 72565000000.00
BAC cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 18526000000.00
BAC balance_sheet (annual, 2022-12-31) — Invested Capital: 547714000000.00
BAC cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2529000000.00
BAC balance_sheet (annual, 2022-12-31) — Investments And Advances: 1043422000000.00
BAC cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 4426000000.00
BAC cash_flow (annual, 2022-12-31) — Issuance Of Debt: 65910000000.00
BAC balance_sheet (annual, 2022-12-31) — Long Term Debt: 275982000000.00
BAC balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 275982000000.00
BAC cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 65910000000.00
BAC cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -34055000000.00
BAC balance_sheet (annual, 2022-12-31) — Long Term Provisions: 1540000000.00
BAC cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -5073000000.00
BAC balance_sheet (annual, 2022-12-31) — Net Debt: 65452000000.00
BAC income_statement (annual, 2022-12-31) — Net Income: 27528000000.00
BAC income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 26015000000.00
BAC income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 27528000000.00
BAC income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 27528000000.00
BAC income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 27528000000.00
BAC cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 27528000000.00
BAC income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 27528000000.00
BAC income_statement (annual, 2022-12-31) — Net Interest Income: 52462000000.00
BAC cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 84103000000.00
BAC cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 35034000000.00
BAC cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 31855000000.00
BAC cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -312000000.00
BAC cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -4612000000.00
BAC balance_sheet (annual, 2022-12-31) — Net PPE: 11510000000.00
BAC cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 3772000000.00
BAC cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 3179000000.00
BAC balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 204175000000.00
BAC income_statement (annual, 2022-12-31) — Normalized Income: 27528000000.00
BAC income_statement (annual, 2022-12-31) — Occupancy And Equipment: 7071000000.00
BAC cash_flow (annual, 2022-12-31) — Operating Cash Flow: -6327000000.00
BAC cash_flow (annual, 2022-12-31) — Operating Gains Losses: -32000000.00
BAC income_statement (annual, 2022-12-31) — Operating Revenue: 94950000000.00
BAC balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 7996777943.00
BAC balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 26932000000.00
BAC balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -21156000000.00
BAC income_statement (annual, 2022-12-31) — Other Gand A: 4021000000.00
BAC cash_flow (annual, 2022-12-31) — Other Non Cash Items: 7927000000.00
BAC income_statement (annual, 2022-12-31) — Other Non Interest Expense: 6279000000.00
BAC balance_sheet (annual, 2022-12-31) — Other Receivables: 13592000000.00
BAC balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 220788000000.00
BAC income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 1513000000.00
BAC balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 222533000000.00
BAC balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 406711800.00
BAC balance_sheet (annual, 2022-12-31) — Preferred Stock: 28397000000.00
BAC income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 1513000000.00
BAC balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 28397000000.00
BAC cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 4426000000.00
BAC cash_flow (annual, 2022-12-31) — Preferred Stock Payments: -654000000.00
BAC income_statement (annual, 2022-12-31) — Pretax Income: 30969000000.00
BAC income_statement (annual, 2022-12-31) — Professional Expense And Contract Services Expense: 2142000000.00
BAC cash_flow (annual, 2022-12-31) — Purchase Of Investment: -159058000000.00
BAC balance_sheet (annual, 2022-12-31) — Receivables: 81135000000.00
BAC income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1978000000.00
BAC cash_flow (annual, 2022-12-31) — Repayment Of Debt: -34055000000.00
BAC cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -5727000000.00
BAC balance_sheet (annual, 2022-12-31) — Retained Earnings: 207003000000.00
BAC income_statement (annual, 2022-12-31) — Salaries And Wages: 36447000000.00
BAC cash_flow (annual, 2022-12-31) — Sale Of Investment: 243161000000.00
BAC income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 5478000000.00
BAC income_statement (annual, 2022-12-31) — Selling General And Administration: 45946000000.00
BAC balance_sheet (annual, 2022-12-31) — Share Issued: 7996777943.00
BAC cash_flow (annual, 2022-12-31) — Stock Based Compensation: 2862000000.00
BAC balance_sheet (annual, 2022-12-31) — Stockholders Equity: 273197000000.00
BAC balance_sheet (annual, 2022-12-31) — Tangible Book Value: 175778000000.00
BAC income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
BAC income_statement (annual, 2022-12-31) — Tax Provision: 3441000000.00
BAC income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.11
BAC balance_sheet (annual, 2022-12-31) — Total Assets: 3051375000000.00
BAC balance_sheet (annual, 2022-12-31) — Total Capitalization: 549179000000.00
BAC balance_sheet (annual, 2022-12-31) — Total Debt: 302914000000.00
BAC balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 273197000000.00
BAC balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 2778178000000.00
BAC balance_sheet (annual, 2022-12-31) — Trading Securities: 180603000000.00
BAC income_statement (annual, 2023-12-31) — +Total Revenue: 102769000000.00
BAC balance_sheet (annual, 2023-12-31) — Accounts Receivable: 81881000000.00
BAC balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 10203000000.00
BAC income_statement (annual, 2023-12-31) — Average Dilution Earnings: 0.00
BAC income_statement (annual, 2023-12-31) — Basic Average Shares: 8028600000.00
BAC income_statement (annual, 2023-12-31) — Basic EPS: 3.10
BAC cash_flow (annual, 2023-12-31) — Beginning Cash Position: 230203000000.00
BAC balance_sheet (annual, 2023-12-31) — Capital Stock: 84762000000.00
BAC balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 341419000000.00
BAC balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 622043000000.00
BAC cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -9087000000.00
BAC balance_sheet (annual, 2023-12-31) — Cash Financial: 27892000000.00
BAC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 93345000000.00
BAC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -35387000000.00
BAC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 44982000000.00
BAC cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -18148000000.00
BAC cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -24304000000.00
BAC cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 44391000000.00
BAC cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -18148000000.00
BAC cash_flow (annual, 2023-12-31) — Change In Working Capital: 2580000000.00
BAC cash_flow (annual, 2023-12-31) — Changes In Cash: 102940000000.00
BAC balance_sheet (annual, 2023-12-31) — Common Stock: 56365000000.00
BAC balance_sheet (annual, 2023-12-31) — Common Stock Equity: 263249000000.00
BAC cash_flow (annual, 2023-12-31) — Common Stock Payments: -4576000000.00
BAC balance_sheet (annual, 2023-12-31) — Current Debt: 32098000000.00
BAC balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 32098000000.00
BAC cash_flow (annual, 2023-12-31) — Deferred Income Tax: -1012000000.00
BAC cash_flow (annual, 2023-12-31) — Deferred Tax: -1012000000.00
BAC cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 2057000000.00
BAC cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2057000000.00
BAC balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 43432000000.00
BAC income_statement (annual, 2023-12-31) — Diluted Average Shares: 8080500000.00
BAC income_statement (annual, 2023-12-31) — Diluted EPS: 3.08